Neo Ivy Capital Management

Position in BMY — Bristol Myers Squibb Co

CIK 1727783 NEW YORK, NY

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,134,758

+$1,578,479 QoQ

Shares Held

54,404

+112.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#678

of 2,506 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $8,085,964 across 5 Drug Manufacturers - General names. BMY ranks #2 (38.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	144,562	$3,481,052
2	BMY	Bristol Myers Squibb Co This page	54,404	$3,134,758
3	ABBV	AbbVie Inc.	3,502	$881,243
4	MRK	Merck & Co., Inc.	3,119	$400,791
5	GILD	Gilead Sciences, Inc.	1,489	$188,120

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,134,758	54,404	+112.0%	Shares	Sole	2026-08-14
2026-03-31	$1,556,279	25,660	+189.5%	Shares	Sole	2026-05-15
2025-09-30	$399,766	8,864	-37.5%	Shares	Sole	2025-11-12
2025-06-30	$656,716	14,187	+8.3%	Shares	Sole	2025-08-12
2023-06-30	$837,617	13,098	-2.3%	Shares	Sole	2023-08-16
2022-12-31	$964,417	13,404	+175.1%	Shares	Sole	2023-03-27
2022-03-31	$355,802	4,872	+155.5%	Shares	Sole	2022-05-16
2021-12-31	$118,901	1,907	+0.7%	Shares	Sole	2022-02-15
2021-03-31	$119,505	1,893	-76.3%	Shares	Sole	2021-10-07
2020-09-30	$482,259	7,999	+491.2%	Shares	Sole	2020-11-17
2020-03-31	$75,416	1,353	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.